header
Image from OpenLibrary

Pharmaceutical study on certain intranasal drug delivery systems using model drug / Raghda Rabe M. Mohammed Hamed ; Supervised Mohamed Farid Elmiligi , Mohamed Ahmed Elnabarawi , Sally Abdelhalim

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Raghda Rabe Mohammed Hamed , 2015Description: 259 P. : charts ; 25cmOther title:
  • دراسه صيدليه على بعض أنظمه التوصيل الدوائى عبر الأنف بإستخدام نموذج عقار [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics Summary: Betahistine dihydrochloride is indicated for the treatment of vertigo, tinnitus, hearing loss and nausea associated with Ménière's syndrome. Betahistine dihydrochloride is generally given by oral route tablets 16 mg and 24 mg. A mild gastric complaints (e.g. vomiting, gastrointestinal pain, abdominal distension and bloating), have been observed. However, a substantial proportion of patients suffer severe nausea or vomiting during their vertigo attack, which may make oral treatment unsatisfactory. Moreover, betahistine dihydrochloride is highly metabolized primarily by the liver (SERC® product monograph - abbott., 2013). The aim of work in this thesis was to formulate betahistine dihydrochloride in certain nasal dosage forms to provide an alternative dosageforms in order to overcome the drug gastrointestinal disturbance side effects and bypass the liver first pass metabolic effect. The work in this thesis is divided into three chapters namely: Chapter I: Formulation and evaluation of betahistine dihydrochloride nasal Gel delivery system. Chapter II: Formulation and evaluation of betahistine dihydrochloride freeze - dried nasal Insert delivery system. Chapter III: Stability study of Selected Formulations of betahistine dihydrochloride nasal Gel and Insert delivery systems
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2015.Ra.P (Browse shelf(Opens below)) Not for loan 01010110067610000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2015.Ra.P (Browse shelf(Opens below)) 67610.CD Not for loan 01020110067610000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics

Betahistine dihydrochloride is indicated for the treatment of vertigo, tinnitus, hearing loss and nausea associated with Ménière's syndrome. Betahistine dihydrochloride is generally given by oral route tablets 16 mg and 24 mg. A mild gastric complaints (e.g. vomiting, gastrointestinal pain, abdominal distension and bloating), have been observed. However, a substantial proportion of patients suffer severe nausea or vomiting during their vertigo attack, which may make oral treatment unsatisfactory. Moreover, betahistine dihydrochloride is highly metabolized primarily by the liver (SERC® product monograph - abbott., 2013). The aim of work in this thesis was to formulate betahistine dihydrochloride in certain nasal dosage forms to provide an alternative dosageforms in order to overcome the drug gastrointestinal disturbance side effects and bypass the liver first pass metabolic effect. The work in this thesis is divided into three chapters namely: Chapter I: Formulation and evaluation of betahistine dihydrochloride nasal Gel delivery system. Chapter II: Formulation and evaluation of betahistine dihydrochloride freeze - dried nasal Insert delivery system. Chapter III: Stability study of Selected Formulations of betahistine dihydrochloride nasal Gel and Insert delivery systems

Issued also as CD

There are no comments on this title.

to post a comment.